Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy: Measures of Immunity and Placental Histopathology : Obstetrics & Gynecology

Secondary Logo

Journal Logo
Advanced Search
Contents: Research Letter

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy

Measures of Immunity and Placental Histopathology

Shanes, Elisheva D. MD; Otero, Sebastian BA; Mithal, Leena B. MD, MSCI; Mupanomunda, Chiedza A. BS; Miller, Emily S. MD, MPH; Goldstein, Jeffery A. MD, PhD

Author Information

Feinberg School of Medicine, Northwestern University, and the Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Corresponding author: Jeffery A. Goldstein, MD, PhD, Olson 2-455, Feinberg School of Medicine, Chicago IL; email: [email protected].

Financial Disclosure The authors did not report any potential conflicts of interest.

Supported by the Friends of Prentice (funder) and NIBIB K08EB030120 (to JAG), Stanley Manne Research Institute and K23AI139337 (to LBM).

Each author has confirmed compliance with the journal's requirements for authorship.

Published online ahead-of-print May 11, 2021.

Peer reviews and author correspondence are available at https://links.lww.com/AOG/C331.

Obstetrics & Gynecology 138(2):p 281-283, August 2021. | DOI: 10.1097/AOG.0000000000004457

In Brief

Receipt of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination was not associated with placental histopathologic lesions.

© 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Log in here >
ACOG Members, please click “Log in here” to access content
Log in here >

Not a Subscriber?

Request Permissions
Become a Society Member

You can read the full text of this article if you:

Access through Ovid